Pure Global: Singapore's AI SaMD Update - The New Pre-Market Compliance Hurdle

This week on ASEAN MedTech Insights, we delve into a major regulatory shift from Singapore's Health Sciences Authority (HSA). A new, mandatory Change Management Program (CMP) has been introduced for all AI-powered Software as a Medical Device (SaMD), fundamentally altering the requirements for market entry. We explore how this new framework moves a critical compliance burden from the post-market phase directly into the initial product registration dossier. This episode is essential for any SaMD manufacturer targeting the ASEAN region, as Singapore's policies often set the standard for neighboring markets. A case in point: A promising AI diagnostics company, armed with full EU approval, planned a rapid launch in Singapore. They are now facing a six-month delay and significant unforeseen costs. Their critical mistake? They failed to prepare the newly required pre-market Change Management Program, bringing their ASEAN expansion to a sudden halt. 本期干货: 1. What exactly is the new Change Management Program (CMP) mandated by the HSA? 2. Why is a CMP now a pre-market requirement instead of a post-market one? 3. What specific documents must be included in your product dossier to satisfy the CMP rules? 4. How does this new Singaporean requirement differ from the EU MDR or US FDA approach to SaMD? 5. Which types of software updates are covered under this new program? 6. What is the biggest mistake companies are making when trying to comply with this new rule? 7. How will this impact the timeline and cost for registering a new AI medical device in Singapore? 8. Are other ASEAN countries expected to adopt similar lifecycle-based regulations? Navigating these evolving regulations requires deep local expertise and a forward-thinking strategy. At Pure Global, we offer end-to-end regulatory consulting solutions for MedTech and IVD companies, using our local knowledge and advanced data tools to streamline your market access. Whether you're a startup or a multinational, we can help you turn these regulatory challenges into opportunities. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.